Expression of CD44 isoforms in human prostate tumor cell lines

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• CD44 is a cell surface glycoprotein involved in cell adhesion and migration.
• Aberrant CD44 expression is implicated in various cancers, including prostate cancer.
• Specific CD44 isoforms, particularly those containing the v6 region, are associated with tumor metastasis.

Purpose of the Study:

• To investigate the expression of CD44 isoforms in human prostate tumor cell lines.
• To determine the presence of standard (CD44s) and variant (including v6) CD44 isoforms at both mRNA and protein levels.
• To explore the potential role of CD44 in prostate cancer progression.

Main Methods:

• Utilized four human prostate tumor cell lines: DU145, LNCaP, PC3, and ND1.
• Analyzed CD44 expression at the protein level using flow cytometry and Western blot.
• Assessed CD44 mRNA expression via reverse transcription-polymerase chain reaction (RT-PCR).

Main Results:

• All four cell lines expressed CD44 standard isoform (CD44s) mRNA; protein expression was observed in three lines (DU145, PC3, ND1).
• Variant CD44 isoforms containing the v6 region were detected at the mRNA level in all cell lines.
• Protein expression of v6 was found in subpopulations of LNCaP and ND1 cells, and soluble CD44 isoforms were detected in supernatants (except LNCaP).

Conclusions:

• Human prostate tumor cell lines express diverse CD44 isoforms, including the v6-containing variant.
• The presence of CD44 isoforms, particularly v6, in prostate cancer cell lines warrants further investigation.
• Preliminary immunohistochemical data suggest altered CD44 expression in human prostatic adenocarcinomas.